製品名:4-(4-Nitrophenyl)piperidine

IUPAC Name:4-(4-nitrophenyl)piperidine

CAS番号:26905-03-3
分子式:C11H14N2O2
純度:95%+
カタログ番号:CM275089
分子量:206.25

包装単位 有効在庫 価格(USD) 数量
CM275089-250mg in stock Ƥſ
CM275089-1g in stock ƋſDz
CM275089-5g 1-2 Weeks ɐƤȌ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:26905-03-3
分子式:C11H14N2O2
融点:-
SMILESコード:O=[N+](C1=CC=C(C2CCNCC2)C=C1)[O-]
密度:
カタログ番号:CM275089
分子量:206.25
沸点:
MDL番号:MFCD06804549
保管方法:

Category Infos

Piperidines
Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.
Piperidine,Piperidine Price
if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.

Column Infos

NX-2127
Existing BTK inhibitors directly bind to the active site of BTK and face challenges such as acquired resistance or incomplete responses over time. PROTAC-induced BTK degradation works as a novel alternative therapy for drug-resistant cancers. The latest journal Science publishes the identification of BTK mutations that are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127.
Nurix Therapeutics’ TPD compound NX-2127 is a first-in-class, dual-function small-molecule protein degrader. It drives targeted BTK and transcription factor IKAROS (IKZF1/3) degradation through ubiquitination and proteasomal degradation, adding combined benefit. NX-2127 is under development of phase I clinical trials that shows promising results and a manageable safety profile for the treatment of relapsed/ refractory B-cell malignancies.

Related Products